https://wiki.tiffa.net/w/index.php?action=history&feed=atom&title=Translations%3ASGLT2_inhibitor%2F41%2FenTranslations:SGLT2 inhibitor/41/en - Revision history2026-07-05T21:00:48ZRevision history for this page on the wikiMediaWiki 1.43.0https://wiki.tiffa.net/w/index.php?title=Translations:SGLT2_inhibitor/41/en&diff=113870&oldid=prevFuzzyBot: Importing a new version from external source2024-02-12T10:46:17Z<p>Importing a new version from external source</p>
<p><b>New page</b></p><div>Gliflozins have been posited to exhibit protective effects on the heart, liver, kidneys, anti‐hyperlipidemic, anti‐[[Atherosclerosis|atherosclerotic]], anti‐[[obesity]], anti‐[[Neoplasm|neoplastic effects]] in ''in vitro'', pre‐clinical, and clinical studies. Pleiotropic effects of this class have been attributed to a variety of its pharmacodynamic actions such as natriuresis, hemoconcentration, deactivation of renin-angiotensin-aldosterone system, ketone body formation, alterations in energy [[homeostasis]], [[glycosuria]], [[lipolysis]], [[Anti-inflammatory|anti‐inflammatory]], and [[Antioxidant|antioxidative]] actions.</div>FuzzyBot